miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
about
MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesSensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway.MicroRNA-targeted therapeutics for lung cancer treatment.MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinomaIdentification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathwayUnique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma.Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.MicroRNAs associated with therapy of non-small cell lung cancer.Genome organization and chromatin analysis identify transcriptional downregulation of insulin-like growth factor signaling as a hallmark of aging in developing B cells
P2860
Q37687364-7B6B14AE-CC49-4C3F-AF64-42ACC66CBC5EQ38641329-3A664325-D532-4101-AF56-BA09CA99D60FQ38703410-B686CB3D-4847-4EB4-8B8B-0DD0455AFB69Q39014580-BBFD69FD-C031-414B-83C0-9F4AEF362685Q41342698-73127ADB-7549-4D95-A76D-39FED18DB186Q41623567-4E78B23C-3B6F-4F43-AC82-33B5E55D93DBQ48518834-CE046451-32E4-4EB2-8350-DA35D4FFC4B7Q52679744-C1EAC866-1CEC-4238-B180-B67E423453F5Q53688073-7256874B-803B-49CB-9F31-FFC881EA8D22Q58763780-93E03DE3-ADC5-4A99-AACF-1DB118E5DA91
P2860
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@ast
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@en
type
label
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@ast
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@en
prefLabel
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@ast
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@en
P2093
P2860
P356
P1476
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway.
@en
P2093
Fengyi Zhao
Haizhen Zhu
Jianguo Sun
Jing Zhang
Zhengtang Chen
P2860
P304
P356
10.3892/IJO.2016.3401
P577
2016-02-19T00:00:00Z